Nothing Special   »   [go: up one dir, main page]

DE60025347D1 - Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests - Google Patents

Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests

Info

Publication number
DE60025347D1
DE60025347D1 DE60025347T DE60025347T DE60025347D1 DE 60025347 D1 DE60025347 D1 DE 60025347D1 DE 60025347 T DE60025347 T DE 60025347T DE 60025347 T DE60025347 T DE 60025347T DE 60025347 D1 DE60025347 D1 DE 60025347D1
Authority
DE
Germany
Prior art keywords
hcg
present
test
sample
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025347T
Other languages
English (en)
Other versions
DE60025347T2 (de
Inventor
John O'connor
Steven Birken
Galina Kovalevskaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Application granted granted Critical
Publication of DE60025347D1 publication Critical patent/DE60025347D1/de
Publication of DE60025347T2 publication Critical patent/DE60025347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60025347T 1999-05-13 2000-05-12 Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests Expired - Lifetime DE60025347T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/311,428 US6927034B2 (en) 1998-02-03 1999-05-13 Methods for detecting trophoblast malignancy by HCG assay
US311428 1999-05-13
PCT/US2000/013197 WO2000070094A1 (en) 1999-05-13 2000-05-12 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY

Publications (2)

Publication Number Publication Date
DE60025347D1 true DE60025347D1 (de) 2006-03-30
DE60025347T2 DE60025347T2 (de) 2006-09-14

Family

ID=23206832

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025347T Expired - Lifetime DE60025347T2 (de) 1999-05-13 2000-05-12 Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests

Country Status (9)

Country Link
US (8) US6927034B2 (de)
EP (1) EP1183390B8 (de)
AT (1) ATE395812T1 (de)
AU (1) AU778130B2 (de)
CA (1) CA2372666C (de)
DE (1) DE60025347T2 (de)
IL (2) IL146454A0 (de)
NZ (1) NZ516024A (de)
WO (1) WO2000070094A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
AU2003251793A1 (en) * 2002-10-10 2004-05-04 Science And Technology Corporation @ Unm Hyperglycosylated hcg (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US20060105411A1 (en) * 2004-11-15 2006-05-18 Cole Laurence A Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
JP2009504659A (ja) * 2005-08-08 2009-02-05 オンコノン・リミテッド・ライアビリティ・カンパニー 抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
WO2007122403A1 (en) * 2006-04-21 2007-11-01 British Pregnancy Advisory Service Device and method for detection of a pregnancy associated hormone
US20080182244A1 (en) * 2006-08-04 2008-07-31 Ikonisys, Inc. Pre-Implantation Genetic Diagnosis Test
WO2009033001A2 (en) * 2007-09-05 2009-03-12 University Of Utah Research Foundation Robust location distinction using teporal link signatures
WO2010030950A2 (en) * 2008-09-12 2010-03-18 University Of Utah Research Foundation Method and system for detecting unauthorized wireless access points using clock skews
US8818288B2 (en) * 2010-07-09 2014-08-26 University Of Utah Research Foundation Statistical inversion method and system for device-free localization in RF sensor networks
MX342210B (es) * 2010-07-13 2016-09-20 Univfy Inc * Metodo para evaluar el riesgo de nacimientos multiples en tratamientos de infertilidad.
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
US8999728B2 (en) * 2011-12-21 2015-04-07 Church & Dwight Co., Inc. Diagnostic detection device
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
WO2016081453A1 (en) * 2014-11-18 2016-05-26 Siemens Healthcare Diagnostics Inc. Lateral flow assay ratio test
WO2018187585A1 (en) * 2017-04-06 2018-10-11 Celmatix Inc. Methods for assessing the potential for reproductive success and informing treatment therefrom
US10470798B1 (en) 2018-11-30 2019-11-12 Ohana Biosciences, Inc. Methods for promoting fertilization
WO2024037724A1 (en) 2022-08-19 2024-02-22 Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) Methods for improving sperm function and fertilizing ability for assisted reproduction techniques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4514505A (en) 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
WO1988004779A1 (en) 1986-12-22 1988-06-30 University Of Queensland Method of treatment of mammals using antibodies to early pregnancy factor (epf)
US5260421A (en) 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
EP0553301A1 (de) 1990-10-17 1993-08-04 Yale University Verfahren zum nachweis und zur verlaufsverfolgung von krebs, schwangerschaft und krankheit des trophoblasten
JPH04300896A (ja) 1991-03-29 1992-10-23 Hiroshi Sueoka ヒト由来の早期妊娠因子及びその分離・精製法
US6339143B1 (en) * 1993-05-13 2002-01-15 The Trustees Of Columbia University In The City Of New York Methods of using antibodies against hormone-related determinants
US6429018B1 (en) * 1996-09-06 2002-08-06 Yale University Prenatal screening for Down's syndrome using hyperglycosylated gonadotropin
DE69624920T2 (de) 1996-09-27 2003-09-18 Inverness Medical Switzerland Gmbh, Zug Testreagentien und Testvorrichtungen
US6927034B2 (en) * 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
KR101301979B1 (ko) 2010-12-21 2013-08-30 주식회사 케이티 근거리 통신을 위한 액세스 포인트를 이용한 위치 측정 방법 및 장치와 액세스 포인트의 위치 추정 방법

Also Published As

Publication number Publication date
US7790403B2 (en) 2010-09-07
WO2000070094A1 (en) 2000-11-23
US20050042702A1 (en) 2005-02-24
US7993858B2 (en) 2011-08-09
US20140087393A1 (en) 2014-03-27
US8163508B2 (en) 2012-04-24
US6927034B2 (en) 2005-08-09
US20030003597A1 (en) 2003-01-02
CA2372666C (en) 2010-02-09
IL146454A (en) 2007-10-31
US8802381B2 (en) 2014-08-12
AU5133400A (en) 2000-12-05
DE60025347T2 (de) 2006-09-14
CA2372666A1 (en) 2000-11-23
ATE395812T1 (de) 2006-01-15
NZ516024A (en) 2004-03-26
EP1183390B8 (de) 2006-05-03
EP1183390A1 (de) 2002-03-06
US7285391B2 (en) 2007-10-23
US20110159526A1 (en) 2011-06-30
US20080108089A1 (en) 2008-05-08
EP1183390B1 (de) 2006-01-04
AU778130B2 (en) 2004-11-18
EP1183390A4 (de) 2003-05-07
US20110300557A1 (en) 2011-12-08
US8420339B2 (en) 2013-04-16
US20150010926A1 (en) 2015-01-08
IL146454A0 (en) 2002-07-25
US20130011858A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
WO1999041584A3 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
WO2006126008A3 (en) Improved immunoassay methods
ATE519109T1 (de) Präeklampsie-diagnose
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
ATE312342T1 (de) Bestimmung eines midregionalen proadrenomedullin- teilpeptids in einer biologischen flüssigkeit zu diagnostischen zwecken sowie immunoassays für die durchführung einer solchen bestimmung
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
DE60228557D1 (de) Candida-nachweis
EP1571160A4 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE430939T1 (de) Schwangerschaftsnachweisverfahren
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE258310T1 (de) Testverfahren für collagenpeptid
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
FI990990A0 (fi) Menetelmä disakkaridaasien määrittämiseksi ja testipakkaus sitä varten
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
GB0001089D0 (en) Lipoprotein assay
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma
NO20016080L (no) Analyse
of the United Biological markers: maintaining standards

Legal Events

Date Code Title Description
8364 No opposition during term of opposition